Matthew Lunning, DO | Authors

Articles

The L-MIND Trial in R/R DLBCL

April 19, 2021

Matthew Lunning, DO, presents the efficacy and safety findings of the L-MIND trial in relapsed/refractory diffuse large B-cell lymphoma and discusses the implications for clinical practice.